U.S. pushing for provision on fair medical device, drug reimbursement in free trade agreement with Asia
Negotiators are debating a section of the planned Trans-Pacific Partnership free trade agreement that would commit the 12 member countries to transparent procedures and fairness in federal medical device and drug reimbursement decisions, AdvaMed Senior Vice President Philip Agress told FierceMedicalDevices.
SAN FRANCISCO--More than a few presentations at the JP Morgan Healthcare conference this week sought to address the future of next-generation sequencing, particularly with the huge waves of related news.
Venture-backed medical device and diagnostics companies are benefiting from a groundswell of investor interest in life sciences that has been spearheaded by great biotech returns for the last several years.
In med tech, here are the top 10 news stories of the year so far, based on web traffic.
Philadelphia's Graphene Frontiers is developing a hand-held, point-of-care diagnostic device that can detect heart attack biomarkers from a drop of blood within minutes, thanks to the use of the company's namesake material.
When the Jumpstart Our Business Startups (JOBS) Act became law, no one was quite sure what, if anything, it would do in practice to encourage the financing of innovative companies. One firm is plowing ahead into this uncharted territory, aiming to push beyond the often consumer-oriented efforts of major crowdfunding sites like Kickstarter and Indiegogo.
Ken Drazan, the head of Johnson & Johnson's California Innovation Center, sat down with FierceMedicalDevices to muse on the company's interest in med tech.
FierceMedicalDevices caught up with Covidien Chief Medical Officer Dr. Michael Tarnoff at the annual AdvaMed conference in Chicago at the beginning of October. Tarnoff also performs minimally invasive and bariatric surgery part-time at Tufts Medical Center in Boston.
Device advice was in abundance at today's Food and Drug Law Institute panel discussion on the industry's compliance with promotion and advertising regs, featuring prominent industry lawyers from Medtronic, Covidien, Abbott and law firms.
Few sectors have been impacted by healthcare reform more than the orthopedics industry. And the looming merger of Zimmer and Biomet threatens to bring even more change and further consolidation. To get another perspective, FierceMedicalDevices spoke with Todd Ebert, the CEO of group purchasing organization Amerinet.